January 6, 2013
Click here to read the full article.
Celldex vaccine rindopepimut cuts death risk from brain cancer, study shows
A new study presented at the Society for Neuro-Oncology conference last week reported that cancer vaccine, rindopepimut, has been shown to reduce the risk of death for glioblastoma (GBM) patients by 47 percent.
Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor
Researchers from Massachusetts General Hospital have reported the first successful use of a targeted therapy drug to treat a debilitating craniopharngioma that recurred after four surgical procedures.
New Computational Strategy Finds Brain Tumor-Shrinking Molecules
A team of researchers from the University of California, San Diego, developed a new computational strategy to find a molecule that shrinks glioblastoma (GBM) tumors by an average of 50 percent.